Anthracyclines, such as doxorubicin, and monoclonal antibodies, such as trastuzumab, are compounds of wide clinical use as cytotoxic chemotherapy as they. Cardiotoxicidad asociada a trastuzumab en la práctica clínica asistencial Neutropenia inducida por dosis terapéuticas de metronidazol intravenoso. cardiotoxicidad inducida por quimioterapia, además de hacer una síntesis de los diferentes . tion (anthracyclines, trastuzumab, tyrosine kinase inhibitors.
|Published (Last):||1 June 2012|
|PDF File Size:||12.60 Mb|
|ePub File Size:||16.98 Mb|
|Price:||Free* [*Free Regsitration Required]|
Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy. Local anaesthetics do not affect protein kinase C function in intact neuroblastoma cells. Kidney damage caused by treatment for hematological malignancies: Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: Effect of a multimodal high intensity exercise intervention in cancer patients undergoing chemotherapy: Intermitted pharmacologic pretreatment by xenon, isoflurane, nitrous oxide, and the opioid morphine prevents tumor necrosis factor alpha-induced adhesion molecule expression in human umbilical vein endothelial cells.
There was a problem providing the content you requested
Colorectal cancer and atrial fibrillation: Federman DG, Henry G. Targeted therapies for metastatic renal cell carcinoma: Goal-directed intraoperative therapy reduces morbidity and length of hospital stay in high-risk surgical patients. Cardiac sudden death; Ventricular fibrillation; Left ventricular function; Echocardiography; Free radicals.
Medina PJ, Goodin S.
Eplerenone in patients with systolic heart failure and mild symptoms. The perioperative management of antithrombotic therapy: Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy. United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia.
Muerte súbita debida a cardiotoxicidad aguda inducida por antraciclinas
Sudden death due to anthracycline-induced acute cardiotoxicity. Biochemical markers for prediction of chemotherapy-induced cardiotoxicity: Cochrane Database Syst Rev. The diagnosis and management of cardiovascular disease in cancer patients.
Guidelines for pre-operative cardiac risk assessment and perioperative trqstuzumab management in non-cardiac surgery. Mechanisms of cardiac dysfunction associated with tyrosine kinase inhibitor cancer therapeutics.
Post-discharge health care needs of patients after lung cancer resection. The data were obtained through the analysis of the medical records of the patients attended at the outpatient clinic from January to December Reversibility of trastuzumab-related cardiotoxicity: Arterial pulse pressure variation predicting fluid responsiveness in critically ill patients.
Early diagnosis of chemotherapy-induced cardiomyopathy: Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion.
Na Tabela 5sugerimos monitoramento por eletrocardiograma ECG. J Heart Lung Transplant. Preclinical evaluation of potential nilotinib cardiotoxicity. Stent thrombosis in a patient receiving chemotherapy. Pentostatin increases the acute toxicity of high dose cyclophosphamide.
Cardiac toxicity from systemic cancer therapy: Singal PK, Iliskovic N. Curr Opin Crit Care. Subacute coronary stent thrombosis in cancer patients.
The analysis of the results of this retrospective study of the medical records of patients with HER2 positive breast cancer trastuzmuab the adverse reactions to the treatment with the monoclonal antibody Trastuzumab, concludes that the monitoring and notification of these adverse events, as well as the need for cardiological follow-up of these patients is of fundamental importance with a focus on the reduction of risks and the benefit of therapeutics.